Description:
This session will provide the audience with relevant, up to date, scientific advances in the field of transplant dermatology that pertains to clinical practice, including the emerging role of viruses in transplant dermatology, management of skin disease secondary to transplant medication and the role of revision of immunosuppression. Analysis on the latest staging and management criteria for high risk SCC will be provided.